HCAT
Health Catalyst, Inc.Company with tickers: HCAT
CIK
1636422
CUSIP
42225T107
Shares Outstanding
73,894,020
13F Activity (30d)
119 filings
117 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $70,756,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $141,940,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Research & Development | $9,779,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Operating Income | $-106,477,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Net Income | $-111,026,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Basic) | $-1.53 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Diluted) | $-1.53 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |